Bausch Health Companies Inc. (BHC): Capital Expenditures
$397.00M
Year ended 2025-12-31
$369.00M
Trailing 12 months to 2026-06-30
+22.1%
3-year compound annual growth
+5.6%
5-year compound annual growth
+5.4%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $397.00M | +17.8% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $337.00M | +56.7% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $215.00M | -1.4% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $218.00M | -19.0% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $269.00M | -10.9% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $302.00M | +11.9% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $270.00M | +72.0% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $157.00M | -8.2% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $171.00M | -27.2% | 2020-02-19, From 2017-01-01 |
| 2016-12-31 | $235.00M | 0.0% | 2019-02-20, From 2016-01-01 |
| 2015-12-31 | $235.00M | -19.5% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $292.00M | +153.3% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $115.30M | +7.2% | 2016-04-29, From 2013-01-01 |
| 2012-12-31 | $107.60M | +83.9% | 2015-02-25, From 2012-01-01 |
| 2011-12-31 | $58.52M | +247.8% | 2014-02-28, From 2011-01-01 |
| 2010-12-31 | $16.82M | +126.6% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $7.42M | -66.3% | 2012-02-29, From 2009-01-01 |
| 2008-12-31 | $22.00M | n/a | 2011-02-28, From 2008-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $397.00M | +17.8% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $621.00M | -5.2% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $437.60M | +47.0% |
| Viatris Inc (VTRS) | 2025-12-31 | $378.80M | +16.2% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $898.40M | +18.9% |
| Organon & Co. (OGN) | 2025-12-31 | $162.00M | -7.4% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $501.00M | +0.6% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $185.84M | -62.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $276.00M | +87.8% |
Compare BHC, ZTS, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗